Shenzhen Salubris Pharmaceuticals Co., Ltd.


  • 尊龙凯时·(中国)app官方网站

    Collaborating with global innovative resources,
    studying pathogenic mechanisms, exploring treatment methods and developing innovative drugs

    Scientific research topics

    A new treatment of renal anemia

    license-in SAL0951, an innovative drug for renal anemia

    learn more

    Efficient and collaborative R&D centers

    Group Research Institute (Shenzhen)

    Focusing on the discovery and development of small molecule innovative drugs, the institute has a highly talented R&D team led by returnees. We have built a sound medical development, operation, data management and statistics system, PV and quality a

    R&D Institute (Chengdu)

    Focusing on the research and development of innovative biologics and biosimilars.; early discovery platforms: antibody screening and optimization, CHO-GS eukaryotic expression system, as well as complete CMC development system, including cell line

    Group Research Institute (USA)

    Located in Maryland, USA, it has gathered a number of well-known new drug experts, who devote themselves to the early research and development of innovative drugs and carry out research on new biopharmaceuticals with global independent intellectual p

    R&D platform

    learn more

    R&D pipeline

    learn more
    友情链接: